吉利德科学(GILD)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GILD 吉利德科学

耶稣受难日休市 04-02 16:00:00 EDT

139.71

-0.59

-0.42%

盘后139.89

+0.18+0.13%

19:57 EDT

最高141.34	最低138.64	成交量492.59万
今开139.61	昨收140.30	日振幅1.92%
总市值1,733亿	流通市值1,730亿	总股本12.41亿
成交额6.88亿	换手率0.40%	流通股本12.38亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"GILD","market":"US","secType":"STK","nameCN":"吉利德科学","latestPrice":139.71,"timestamp":1775160000000,"preClose":140.3,"halted":0,"volume":4925897,"hourTrading":{"tag":"盘后","latestPrice":139.89,"preClose":139.71,"latestTime":"19:57 EDT","volume":570693,"amount":79722565.9445,"timestamp":1775174236820,"change":0.18,"changeRate":0.001288,"amplitude":0.004652},"delay":0,"changeRate":-0.0042052744119743645,"floatShares":1238162880,"shares":1240679623,"eps":6.78,"marketStatus":"耶稣受难日休市","change":-0.59,"latestTime":"04-02 16:00:00 EDT","open":139.61,"high":141.34,"low":138.64,"amount":688168745.96225,"amplitude":0.019244,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":6.78,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1775462400000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":696056400000,"exchange":"NASDAQ","adjPreClose":140.3,"dividendRate":0.022618,"preHourTrading":{"tag":"盘前","latestPrice":139.98,"preClose":140.3,"latestTime":"09:29 EDT","volume":215040,"amount":30169378.713600002,"timestamp":1775136597769,"change":-0.32,"changeRate":-0.002281,"amplitude":0.019244},"postHourTrading":{"tag":"盘后","latestPrice":139.89,"preClose":139.71,"latestTime":"19:57 EDT","volume":570693,"amount":79722565.9445,"timestamp":1775174236820,"change":0.18,"changeRate":0.001288,"amplitude":0.004652},"volumeRatio":0.8422677003257983,"impliedVol":0.3519,"impliedVolPercentile":0.6574},"requestUrl":"/m/hq/s/GILD","defaultTab":"news","newsList":[{"id":"1125354028","title":"Galapagos与吉利德科学达成具有约束力协议 携手推进自身免疫性疾病领域首创T细胞衔接器项目","url":"https://stock-news.laohu8.com/highlight/detail?id=1125354028","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1125354028?lang=zh_cn&edition=full","pubTime":"2026-03-31 13:32","pubTimestamp":1774935153,"startTime":"0","endTime":"0","summary":"Galapagos公司与吉利德科学（Gilead Sciences）近日签署了一项具有约束力的合作协议，双方将共同推进针对自身免疫性疾病的首创T细胞衔接器项目。这一合作标志着两家公司在免疫疗法领域的重要进展，旨在通过创新疗法为自身免疫性疾病患者提供新的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1674673691.USD","LU0823416689.USD","LU0965508806.USD","IE00B19Z3B42.SGD","BK4585","IE00B19Z3581.USD","BK4588","BK4568","LU1023059063.AUD","LU1934455277.USD","SG9999015952.SGD","LU0965509101.SGD","LU0882574055.USD","BK4139","LU1839511570.USD","LU0289739699.SGD","BK4550","LU1674673428.USD","LU1061106388.HKD","LU1571399168.USD","BK4532","LU1066053197.SGD","LU0122379950.USD","LU0320765992.SGD","IE00BSNM7G36.USD","IE00B7SZLL34.SGD","LU0861579265.USD","LU0965509010.AUD","LU0889565916.HKD","SG9999015986.USD","BK4566","BK4578","LU1057294990.SGD","LU2324357040.USD","LU2112291526.USD","LU1934455863.HKD","LU2089984988.USD","LU0114720955.EUR","LU1934455194.USD","LU1585245621.USD","BK4583","LU2087621335.USD","SG9999015978.USD","IE00BZ1G4Q59.USD","SG9999015945.SGD","LU1066051498.USD","LU0234570918.USD","LU0058720904.USD","LU1778281490.HKD","LU1430594728.SGD","LU0965509283.SGD","IE00BKVL7J92.USD","LU0109394709.USD","LU1037948541.HKD","LU1037948897.HKD","LU2468319806.SGD","GILD","IE0002270589.USD","IE00B3T34201.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139494294","title":"Galapagos NV拟独立支出5亿美元，其中最高1.5亿美元用于股份回购或股息","url":"https://stock-news.laohu8.com/highlight/detail?id=1139494294","media":"美股速递","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139494294?lang=zh_cn&edition=full","pubTime":"2026-03-31 13:32","pubTimestamp":1774935140,"startTime":"0","endTime":"0","summary":"生物技术公司Galapagos NV宣布，计划自主调配高达5亿美元资金，用于支持公司战略发展。这一资金安排中，预计最多1.5亿美元将专项用于股份回购计划或向股东派发股息，其余部分将投入研发及业务拓展。此次资金部署彰显了公司强化财务灵活性的决心，同时兼顾股东回报与长期增长需求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0122379950.USD","LU2089984988.USD","BK4583","LU1571399168.USD","LU2324357040.USD","LU0889565916.HKD","BK4550","IE00BSNM7G36.USD","BK4588","LU0861579265.USD","LU0114720955.EUR","LU0965508806.USD","LU1934455863.HKD","LU1066053197.SGD","LU1037948541.HKD","LU1037948897.HKD","IE00B19Z3B42.SGD","IE00BZ1G4Q59.USD","BK4585","SG9999015978.USD","LU2468319806.SGD","LU0965509010.AUD","LU1839511570.USD","LU1430594728.SGD","IE00BKVL7J92.USD","LU1066051498.USD","LU2112291526.USD","BK4578","LU0058720904.USD","LU0965509101.SGD","LU1934455194.USD","BK4532","LU1585245621.USD","IE0002270589.USD","LU1934455277.USD","LU0289739699.SGD","LU0823416689.USD","LU1023059063.AUD","LU2087621335.USD","LU0965509283.SGD","LU1061106388.HKD","SG9999015986.USD","IE00B3T34201.USD","LU1057294990.SGD","LU1778281490.HKD","GILD","BK4566","LU1674673691.USD","LU0109394709.USD","IE00B19Z3581.USD","SG9999015945.SGD","IE00B7SZLL34.SGD","LU1674673428.USD","BK4568","LU0320765992.SGD","LU0882574055.USD","SG9999015952.SGD","BK4139","LU0234570918.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621956096","title":"吉利德拟以最高21.75亿美元收购Ouro Medicines","url":"https://stock-news.laohu8.com/highlight/detail?id=2621956096","media":"金吾财讯","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621956096?lang=zh_cn&edition=full","pubTime":"2026-03-24 23:10","pubTimestamp":1774365049,"startTime":"0","endTime":"0","summary":"金吾财讯 | 吉利德科学宣布，已签署最终协议收购Ouro Medicines，后者一家专注于开发针对自体免疫疾病疗法的私营生物技术公司。吉利德支付16.75亿美元的预付现金对价(需进行惯例调整)，外加最高5亿美元的或有里程碑付款。该交易为吉利德的炎症产品组合增添了OM336(gamgertamig)，这是一种处于临床阶段的BCMAxCD3 T细胞衔接器。在正在进行的1/2期临床研究中，该药物在严重自体免疫疾病(包括自体免疫性溶血性贫血和免疫性血小板减少症)中显示出疗效。OM336已获得快速通道资格和孤儿药资格。","market":"us","thumbnail":"https://static.szfiu.com/news/20210625/YzM5OTgzZmE3NTA3Njg3Nzc4Mjg=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/YzM5OTgzZmE3NTA3Njg3Nzc4Mjg=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"298333","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3T34201.USD","LU0109394709.USD","BK4566","LU0058720904.USD","LU2112291526.USD","LU1066051498.USD","LU0289739699.SGD","LU1057294990.SGD","LU0965508806.USD","BK4585","LU1934455194.USD","LU1934455277.USD","LU1037948541.HKD","LU0861579265.USD","BK4578","GILD","LU0965509010.AUD","LU1571399168.USD","LU0882574055.USD","LU1674673691.USD","SG9999015945.SGD","SG9999015986.USD","IE00BZ1G4Q59.USD","LU0320765992.SGD","LU1023059063.AUD","IE00B7SZLL34.SGD","SG9999015952.SGD","LU1066053197.SGD","IE00BKVL7J92.USD","LU2468319806.SGD","LU1061106388.HKD","BK4568","LU1674673428.USD","LU2089984988.USD","LU0122379950.USD","BK4583","BK4139","IE00B19Z3581.USD","IE00B19Z3B42.SGD","SG9999015978.USD","LU1585245621.USD","LU1430594728.SGD","LU1934455863.HKD","LU0823416689.USD","BK4588","LU1839511570.USD","IE0002270589.USD","LU2087621335.USD","LU0889565916.HKD","IE00BSNM7G36.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123197269","title":"吉利德科学保留大中华区以外全球独家商业化权利，将向Galapagos支付销售额20%-23%的特许权使用费","url":"https://stock-news.laohu8.com/highlight/detail?id=1123197269","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1123197269?lang=zh_cn&edition=full","pubTime":"2026-03-24 06:17","pubTimestamp":1774304236,"startTime":"0","endTime":"0","summary":"根据最新协议条款，生物制药巨头吉利德科学将保留除大中华区以外的全球独家商业化权利。与此同时，该公司承诺将向合作伙伴Galapagos支付相当于净销售额20%至23%的特许权使用费。这一安排凸显了吉利德科学在全球市场战略布局中的精准定位，同时通过阶梯式分成模式强化了双方的利益共享机制。值得注意的是，大中华区的商业化权利将采用独立运作模式，这反映出该地区在市场规模、监管环境等方面具备的特殊性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4578","LU1037948897.HKD","BK4550","IE00BSNM7G36.USD","LU0289739699.SGD","IE00B7SZLL34.SGD","LU1674673691.USD","LU1674673428.USD","LU1934455277.USD","LU1066053197.SGD","LU2324357040.USD","BK4583","IE00B3T34201.USD","BK4588","LU0320765992.SGD","LU1571399168.USD","LU0861579265.USD","LU2089984988.USD","LU1066051498.USD","LU0965509010.AUD","IE00BZ1G4Q59.USD","LU2112291526.USD","LU1057294990.SGD","LU0109394709.USD","LU0234570918.USD","SG9999015945.SGD","IE00B19Z3B42.SGD","IE00BKVL7J92.USD","LU1585245621.USD","SG9999015986.USD","LU1037948541.HKD","SG9999015952.SGD","LU1061106388.HKD","LU0114720955.EUR","BK4568","BK4139","BK4532","LU0882574055.USD","LU0965508806.USD","LU2087621335.USD","LU1778281490.HKD","SG9999015978.USD","LU2468319806.SGD","LU0965509283.SGD","BK4585","LU1934455863.HKD","LU0889565916.HKD","LU1934455194.USD","IE0002270589.USD","IE00B19Z3581.USD","LU0058720904.USD","LU0823416689.USD","LU1430594728.SGD","LU1023059063.AUD","LU0122379950.USD","GILD","LU0965509101.SGD","LU1839511570.USD","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156422664","title":"吉利德科学将以16.75亿美元现金对价收购Ouro Medicines全部流通股权","url":"https://stock-news.laohu8.com/highlight/detail?id=1156422664","media":"美股速递","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1156422664?lang=zh_cn&edition=full","pubTime":"2026-03-24 06:16","pubTimestamp":1774304173,"startTime":"0","endTime":"0","summary":"吉利德科学宣布，将以总额16.75亿美元的前期现金对价，收购生物技术公司Ouro Medicines的全部流通股权。此次交易将强化吉利德在创新疗法领域的布局，通过整合Ouro Medicines的专有技术平台，加速下一代治疗方案的开发进程。\n该收购案预计将于近期完成，届时Ouro Medicines的研发团队及技术资产将悉数并入吉利德科学的运营体系。市场观察人士指出，此举反映了大型药企通过战略性收购增强核心竞争力的趋势，尤其在基因编辑与细胞治疗等前沿领域。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1674673691.USD","LU0823416689.USD","LU0965508806.USD","IE00B19Z3B42.SGD","BK4585","IE00B19Z3581.USD","BK4588","BK4568","LU1023059063.AUD","LU1934455277.USD","SG9999015952.SGD","LU0965509101.SGD","LU0882574055.USD","BK4139","LU1839511570.USD","LU0289739699.SGD","BK4550","LU1674673428.USD","LU1061106388.HKD","LU1571399168.USD","BK4532","LU1066053197.SGD","LU0122379950.USD","LU0320765992.SGD","IE00BSNM7G36.USD","IE00B7SZLL34.SGD","LU0861579265.USD","LU0965509010.AUD","LU0889565916.HKD","SG9999015986.USD","BK4566","BK4578","LU1057294990.SGD","LU2324357040.USD","LU2112291526.USD","LU1934455863.HKD","LU2089984988.USD","LU0114720955.EUR","LU1934455194.USD","LU1585245621.USD","BK4583","LU2087621335.USD","SG9999015978.USD","IE00BZ1G4Q59.USD","SG9999015945.SGD","LU1066051498.USD","LU0234570918.USD","LU0058720904.USD","LU1778281490.HKD","LU1430594728.SGD","LU0965509283.SGD","IE00BKVL7J92.USD","LU0109394709.USD","LU1037948541.HKD","LU1037948897.HKD","LU2468319806.SGD","GILD","IE0002270589.USD","IE00B3T34201.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172994317","title":"吉利德科学正与Galapagos就收购的Ouro Medicines资产展开研发合作深入谈判","url":"https://stock-news.laohu8.com/highlight/detail?id=1172994317","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1172994317?lang=zh_cn&edition=full","pubTime":"2026-03-24 06:16","pubTimestamp":1774304171,"startTime":"0","endTime":"0","summary":"吉利德科学目前正与Galapagos公司进行深入磋商，双方拟就吉利德收购的Ouro Medicines资产展开潜在的研发合作。此次谈判标志着两家公司在创新药物开发领域的战略协同进入新阶段。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4583","GILD","LU1839511570.USD","LU2324357040.USD","SG9999015952.SGD","LU0882574055.USD","LU0122379950.USD","BK4550","LU1934455863.HKD","LU1585245621.USD","LU0861579265.USD","IE00B7SZLL34.SGD","LU1066053197.SGD","LU0109394709.USD","LU0965508806.USD","LU0965509283.SGD","BK4532","LU1037948541.HKD","LU1674673428.USD","LU2468319806.SGD","SG9999015986.USD","IE0002270589.USD","LU0114720955.EUR","LU0965509010.AUD","LU1674673691.USD","LU0965509101.SGD","LU0889565916.HKD","LU0823416689.USD","LU1037948897.HKD","LU1571399168.USD","BK4139","IE00BZ1G4Q59.USD","LU1066051498.USD","LU2087621335.USD","IE00BSNM7G36.USD","IE00BKVL7J92.USD","BK4588","IE00B3T34201.USD","LU1023059063.AUD","LU2089984988.USD","BK4585","LU1061106388.HKD","LU2112291526.USD","BK4568","LU0058720904.USD","LU0234570918.USD","IE00B19Z3581.USD","LU1934455277.USD","BK4578","LU1778281490.HKD","LU0289739699.SGD","SG9999015978.USD","LU1934455194.USD","BK4566","IE00B19Z3B42.SGD","SG9999015945.SGD","LU1430594728.SGD","LU1057294990.SGD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145865834","title":"吉利德科学将收购Ouro Medicines，推进其首创的T细胞衔接器项目以治疗自身免疫性疾病","url":"https://stock-news.laohu8.com/highlight/detail?id=1145865834","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145865834?lang=zh_cn&edition=full","pubTime":"2026-03-24 06:16","pubTimestamp":1774304170,"startTime":"0","endTime":"0","summary":"吉利德科学已达成协议，将收购Ouro Medicines公司，此举旨在加速推进其首创的T细胞衔接器项目，该项目的重点在于开发针对自身免疫性疾病的创新疗法。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1430594728.SGD","SG9999015945.SGD","LU0234570918.USD","BK4585","LU2324357040.USD","LU0114720955.EUR","LU1585245621.USD","LU1778281490.HKD","LU0289739699.SGD","BK4550","BK4532","LU1674673691.USD","IE00BSNM7G36.USD","LU0965509010.AUD","BK4566","LU2468319806.SGD","BK4583","BK4588","SG9999015952.SGD","LU1023059063.AUD","LU0823416689.USD","BK4139","LU0861579265.USD","LU1934455277.USD","SG9999015978.USD","LU0320765992.SGD","BK4568","LU2112291526.USD","LU0122379950.USD","IE00B19Z3B42.SGD","LU0889565916.HKD","LU1839511570.USD","LU2087621335.USD","LU0882574055.USD","BK4578","GILD","LU1571399168.USD","LU1037948897.HKD","LU1061106388.HKD","LU1066051498.USD","LU2089984988.USD","IE00BZ1G4Q59.USD","IE0002270589.USD","LU1934455194.USD","IE00B7SZLL34.SGD","LU0965509283.SGD","LU1674673428.USD","LU0965508806.USD","IE00B19Z3581.USD","LU0965509101.SGD","LU1057294990.SGD","LU1066053197.SGD","LU0058720904.USD","LU0109394709.USD","SG9999015986.USD","LU1037948541.HKD","IE00BKVL7J92.USD","IE00B3T34201.USD","LU1934455863.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175690757","title":"吉利德科学与Ouro Medicines谈判进入后期阶段 交易有望近日公布","url":"https://stock-news.laohu8.com/highlight/detail?id=1175690757","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1175690757?lang=zh_cn&edition=full","pubTime":"2026-03-24 00:37","pubTimestamp":1774283835,"startTime":"0","endTime":"0","summary":"据知情人士透露，生物制药巨头吉利德科学与生物技术公司Ouro Medicines的并购谈判已进入关键阶段。双方正就最终条款进行磋商，若谈判顺利，这项备受业界关注的交易可能在未来数日内正式对外公告。此次潜在收购将强化吉利德在创新疗法领域的战略布局。市场观察人士指出，此举延续了吉利德近年来通过并购加速创新的战略路径。随着谈判进入收官阶段，两家公司股价近日均呈现波动上行态势。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2324357040.USD","SG9999015945.SGD","LU0882574055.USD","LU2468319806.SGD","LU1674673691.USD","LU1037948897.HKD","BK4585","LU0122379950.USD","LU1066053197.SGD","SG9999015952.SGD","LU0109394709.USD","LU0861579265.USD","LU2089984988.USD","BK4532","LU2112291526.USD","LU1778281490.HKD","SG9999015978.USD","GILD","BK4566","BK4568","LU0320765992.SGD","LU1430594728.SGD","IE00BKVL7J92.USD","IE00B19Z3581.USD","IE00BZ1G4Q59.USD","LU0234570918.USD","LU0823416689.USD","LU1023059063.AUD","LU1066051498.USD","LU1934455194.USD","LU0965508806.USD","IE00B3T34201.USD","LU0058720904.USD","BK4588","BK4139","LU0114720955.EUR","IE00B19Z3B42.SGD","BK4578","LU0289739699.SGD","LU0889565916.HKD","LU0965509283.SGD","LU1057294990.SGD","LU1934455277.USD","LU1571399168.USD","LU1061106388.HKD","LU0965509010.AUD","LU1674673428.USD","LU1934455863.HKD","LU2087621335.USD","LU0965509101.SGD","LU1037948541.HKD","LU1585245621.USD","LU1839511570.USD","BK4583","IE00BSNM7G36.USD","IE0002270589.USD","SG9999015986.USD","IE00B7SZLL34.SGD","BK4550"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102792638","title":"吉利德科学将以约15亿美元现金预付款收购Ouro，若临床试验达标还将额外支付至少5亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1102792638","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102792638?lang=zh_cn&edition=full","pubTime":"2026-03-24 00:37","pubTimestamp":1774283833,"startTime":"0","endTime":"0","summary":"吉利德科学将向私人控股的Ouro公司投资者支付约15亿美元现金作为预付款。此外，若达成特定临床试验里程碑，吉利德科学还将额外支付至少5亿美元资金。该交易结构凸显了生物医药行业对创新疗法的高估值趋势，资金支付与研发进展深度绑定的模式也成为当前并购交易的新特征。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823416689.USD","SG9999015945.SGD","LU2087621335.USD","LU1037948541.HKD","LU1934455863.HKD","LU1061106388.HKD","LU0882574055.USD","LU1674673691.USD","IE00BZ1G4Q59.USD","LU1585245621.USD","LU0965509101.SGD","LU0861579265.USD","LU0122379950.USD","LU2468319806.SGD","BK4550","LU1037948897.HKD","LU1571399168.USD","BK4139","IE00BKVL7J92.USD","GILD","LU0058720904.USD","LU1778281490.HKD","LU0965509283.SGD","SG9999015952.SGD","LU1839511570.USD","IE00B3T34201.USD","IE00B19Z3581.USD","BK4585","LU1430594728.SGD","SG9999015978.USD","BK4578","LU0234570918.USD","LU1057294990.SGD","BK4566","SG9999015986.USD","IE00BSNM7G36.USD","LU2112291526.USD","LU0289739699.SGD","LU1934455277.USD","BK4583","LU0965509010.AUD","LU0965508806.USD","BK4532","LU1066053197.SGD","LU1674673428.USD","LU2089984988.USD","IE00B7SZLL34.SGD","LU1934455194.USD","BK4568","LU1066051498.USD","BK4588","LU1023059063.AUD","LU2324357040.USD","LU0109394709.USD","LU0114720955.EUR","IE00B19Z3B42.SGD","LU0320765992.SGD","LU0889565916.HKD","IE0002270589.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620225813","title":"吉利德科学(GILD.US)CD19/CD20 CAR-T细胞疗法启动III期临床","url":"https://stock-news.laohu8.com/highlight/detail?id=2620225813","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620225813?lang=zh_cn&edition=full","pubTime":"2026-03-19 21:12","pubTimestamp":1773925932,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，3月18日，美国临床试验收录网站显示，吉利德科学旗下公司Kite Pharma启动了KITE-753的首个III期临床试验。KITE-753是一款靶向CD19和CD20的双顺反子自体CAR-T细胞疗法。研究的主要终点是第6个月实现完全缓解的患者比例和36个月内的无事件生存期。结果显示，剂量3队列，在14例未接受过CAR-T细胞疗法治疗的患者中，11例实现CR，CR率为79%;总人群，在20例未接受过CAR-T细胞疗法治疗的患者中，14例实现CR，CR率为70%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1416170.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1430594728.SGD","LU0882574055.USD","LU1023059063.AUD","SG9999015945.SGD","LU2089984988.USD","LU0114720955.EUR","LU0122379950.USD","LU1674673691.USD","LU1066051498.USD","BK4532","GILD","LU1934455863.HKD","IE00B3T34201.USD","LU1839511570.USD","LU0965508806.USD","LU1571399168.USD","SG9999015986.USD","LU1037948897.HKD","LU1061106388.HKD","LU2087621335.USD","IE00BKVL7J92.USD","LU0889565916.HKD","LU0823416689.USD","III","LU0234570918.USD","SG9999015978.USD","BK4134","LU1674673428.USD","LU0058720904.USD","LU0861579265.USD","LU0965509010.AUD","LU0965509101.SGD","BK4139","BK4588","IE00B19Z3581.USD","LU2112291526.USD","LU1585245621.USD","IE00B19Z3B42.SGD","CAR","BK4583","BK4568","BK4022","LU1066053197.SGD","LU1037948541.HKD","IE00BZ1G4Q59.USD","LU0965509283.SGD","IE0002270589.USD","LU0109394709.USD","SG9999015952.SGD","LU0289739699.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618188727","title":"华尔街机构的钱都去哪了？美银最新报告：全在AI里，Palantir(PLTR.US)、博通(AVGO.US)排队吸金","url":"https://stock-news.laohu8.com/highlight/detail?id=2618188727","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618188727?lang=zh_cn&edition=full","pubTime":"2026-03-12 14:43","pubTimestamp":1773297797,"startTime":"0","endTime":"0","summary":"博通、Arista Networks、安费诺等AI产业链及半导体关联企业，机构持股同样大幅增长，凸显机构资金正全面转向AI基础设施与数据技术领域。Meta、奈飞等大型通信服务企业，同样获得机构新增持仓。前五名其余个股为西部数据、博通、GE Vernova，均为“持有”评级。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1413031.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0354030511.USD","LU0985320562.USD","APH","LU0823434740.USD","IE00BJTD4V19.USD","IE00BJTD4N35.SGD","LU2298321311.HKD","BK4512","LU0444971666.USD","LU2860962120.EUR","LU2092937221.SGD","LU2347655073.USD","LU0096364046.USD","SGXZ99366536.SGD","LU0820561909.HKD","LU2272731782.SGD","LU0057025933.USD","LU2360106780.USD","LU2360032135.SGD","LU2487616109.SGD","IE00BN8TJ469.HKD","LU2417539215.USD","LU1674673428.USD","LU1623119135.USD","IE00BYV24P56.USD","LU1323610961.USD","LU0889565833.HKD","LU2602419157.SGD","LU0320765646.SGD","LU0642271901.SGD","LU2756315318.SGD","LU0053666078.USD","LU2750360997.AUD","IE00BVYPNW00.USD","LU1670710661.SGD","LU1861558580.USD","LU2168564065.EUR","PLTR","LU2264538146.SGD","LU1037948897.HKD","LU2063271972.USD","LU0965509283.SGD","LU1951198990.SGD","IE00BKVL7J92.USD","PLTD","LU2237443978.SGD","LU0476273544.USD","IE00BQXX3F31.USD","LU2471134523.USD","LU2242649171.HKD","PLTI","LU0345770993.USD","SG9999001424.SGD","LU2361044865.SGD","LU1629891620.HKD","LU2065170008.USD","LU0048584097.USD","PLTW","LU1989764748.USD","IE0034235188.USD","BK4551","BK4598","LU2087625088.SGD","LU0124676726.USD","LU1244550221.USD","LU0820562030.AUD","LU2592432038.USD","GEV","SG9999015986.USD","LU1868836757.USD","LU0234570918.USD","LU0672654240.SGD","LU2168564149.EUR","BK4554","LU1691799644.USD","IE00BK4W5M84.HKD","PLTG","IE00B3S45H60.SGD","LU0943347566.SGD","IE00BK4W5L77.USD","LU2125154935.USD","LU1670711123.USD","LU0965509010.AUD","LU0234572021.USD","IE00BLSP4452.SGD","LU2237443382.USD","LU0795875169.SGD","PLTY","LU1935042991.SGD","LU1232071149.USD","LU0640476718.USD","LU1868837300.USD","LU1992135472.HKD","LU2746668974.SGD","IE00BZ9MQY76.HKD","LU2041044095.USD","LU0316494557.USD","LU0069063385.USD","LU2420271590.USD","LU0289961442.SGD","LU1366333091.USD","LU2764263039.SGD","LU0949170426.SGD","LU2065171311.SGD","LU0210533765.USD","LU2237443465.HKD","LU1935042488.USD","LU1242518931.SGD","LU1548497426.USD","LU2322448957.HKD","LU1923623000.USD","IE00BN29S564.USD","LU0545039389.USD","LU1145028129.USD","LU1670711040.USD","LU1815336760.USD","IE00BMCWC346.EUR","IE00BBT3K403.USD","LU0011850046.USD","LU2355687059.USD","LU0345768740.USD","LU2430703251.USD","LU0203345920.USD","LU2083900584.USD","AVGX","LU0251132253.USD","LU2746668461.USD","LU0868494708.USD","LU1778281490.HKD","LU0823434583.USD","IE00B19Z9Z06.USD","LU2065171402.SGD","LU1069344957.HKD","LU2764262908.HKD","SG9999015945.SGD","BK4543","LU1868837136.USD","LU0417517546.SGD","LU2720916845.USD","LU0345768153.USD","LU2237438978.USD","IE0001KFT4U8.USD","IE00BVYPNP33.GBP","LU2471134879.HKD","SGXZ51526630.SGD","LU2211814178.USD","LU0795875086.SGD","LU1551013342.USD","LU0154236417.USD","IE00BKPKM429.USD","LU0082616367.USD","LU0511384066.AUD","LU2764263203.CNY","BK4515","IE00B4JS1V06.HKD","LU1732800096.USD","LU0256863902.USD","LU1244550494.USD","LU2473716301.USD","LU1316542783.SGD","SG9999015952.SGD","LU0868494617.USD","BK4612","LU0353189680.USD","LU2456880835.USD","LU2247934214.USD","IE0004445239.USD","LU0274383776.USD","PTIR","IE00BMPRXN33.USD","GILD","LU0106261372.USD","LU1642822529.SGD","LU0187121727.USD","LU0345769128.USD","LU1551013425.SGD","LU1280957306.USD","IE00B42XCP33.USD","LU0820561818.USD","BK4547","BK4613","IE00BQXX3C00.GBP","LU2054465674.USD","LU1951200564.SGD","LU0784383803.USD","LU1162221912.USD","LU2237443895.HKD","SG9999001440.SGD","LU0861579265.USD","LU2237957811.SGD","LU1366192091.USD","BK4605","LU0957791311.USD","LU2236285917.USD","LU2023250504.SGD","AVL","PLT","LU2168563687.JPY","LU1127390331.HKD","IE00B7KXQ091.USD","IE00BFSS8Q28.SGD","LU0198837287.USD","IE00B775H168.HKD","LU1934455277.USD","LU2361045086.USD","LU2023250330.USD","LU0345770308.USD","SGXZ23171101.USD","BK4575","IE00BVYPNQ40.USD","LU2360108059.USD","LU1861559042.SGD","IE00BMPRXQ63.HKD","LU0061475181.USD","LU1935043023.USD","LU1974910355.USD","LU2237443622.USD","LU0096362180.USD","SG9999004303.SGD","IE00BDGV0183.EUR","LU0965508806.USD","IE00B5949003.HKD","SG9999015978.USD","BK4585","LU2505996681.GBP","LU0444973449.USD","IE00BJLML261.HKD","LU0203201768.USD","LU2471134796.USD","LU0157215616.USD","LU2242650005.HKD","IE00B19Z9P08.USD","LU1064131342.USD","LU2286300806.USD","SG9999011175.SGD","IE00BGHQF631.EUR","LU0787776722.HKD","LU0689472784.USD","LU0345769631.USD","IE00BVYPNV92.GBP","AVGG","PLTZ","IE00BLSP4239.USD","PLTU","LU0708995401.HKD","SG9999002232.USD","LU2430703178.SGD","LU1670628061.USD","LU0784384876.USD","IE0004445015.USD","BK4533","LU2750360641.GBP","IE00B894F039.SGD","LU2108987350.USD","LU0466842654.USD","LU0097036916.USD","LU2244417387.USD","LU1035775433.USD","PLTA","LU2168564495.EUR","LU2361044949.HKD","LU0203347892.USD","BK4141","LU2505996509.AUD","IE0034235303.USD","LU0323591593.USD","LU0784385170.HKD","LU2896262040.SGD","LU0661504455.SGD","LU0689626769.HKD","LU2462157665.USD","IE00BKDWB100.SGD","AVS","LU0784385840.USD","ANET","LU2133065610.SGD","LU1003077747.HKD","IE00BFSS7M15.SGD","LU0238689110.USD","BK4023","LU2458330243.SGD","LU1804176565.USD","LU1868836591.USD","LU0215105999.USD","IE00B1XK9C88.USD","LU2089985449.USD","AVGU","LU0957808578.USD","LU0942090050.USD","LU0726765562.USD","LU0683600562.USD","IE00BJJMRX11.SGD","LU0348723411.USD","LU0006306889.USD","LU1720051108.HKD","AVGW","LU1917777945.USD","LU2756315664.SGD","LU0738911758.USD","LU1670710588.SGD","LU1914381329.SGD","LU0079474960.USD","IE00BWXC8680.SGD","LU0081259029.USD","LU1815333072.USD","LU0256863811.USD","LU1153585028.USD","LU1934455863.HKD","LU0210528500.USD","LU1814569148.SGD","LU1935043536.SGD","LU0964807845.USD","LU2125154778.USD","LU0225283273.USD","IE00BJJMRY28.SGD","LU0354030438.USD","LU0719512351.SGD","SG9999002224.SGD","BK4566","LU1037948541.HKD","LU0289739343.SGD","LU0320765059.SGD","LU2237443549.SGD","LU0553294199.USD","LU1244550577.SGD","LU0203202063.USD","LU2265009873.SGD","LU1301847155.USD","PLYY","LU2403377893.USD","IE00B3PB1722.GBP","LU2357305700.SGD","IE00BZ1G4Q59.USD","LU2931357623.SGD","LU0353189763.USD","LU0127658192.USD","LU2279689827.SGD","LU0786609619.USD","LU1732799900.SGD","LU2211815571.USD","LU2347655156.SGD","LU2471134952.CNY","LU1670627923.USD","LU0109391861.USD","LU0965509101.SGD","LU1267930730.SGD","LU0109392836.USD","IE0005OL40V9.USD","IE00BGHQDM52.EUR","LU0472753341.HKD","IE00B1BXHZ80.USD","SGXZ81514606.USD","LU0912757837.SGD","LU1852331112.SGD","AVGO","LU1868836914.USD","LU2463028550.USD","SG9999003800.SGD","LU2322448791.USD","LU1935042215.USD","LU0949170772.SGD","LU2430703095.HKD","LU2543165471.USD","LU1934455194.USD","LU1712237335.SGD","BK4588","LU1988902786.USD","LU1674673691.USD","IE00BQXX3D17.EUR","LU0061474960.USD","LU2272731600.USD","LU1992135399.USD","LU0056508442.USD","BK4581","LU2461242641.AUD","LU0210536198.USD","LU1720051017.SGD","LU2106854487.HKD","LU2065169927.USD","LU2458330169.SGD","IE00BMPRXR70.SGD","LU0979878070.USD","IE0009356076.USD","LU0170899867.USD","LU2250418816.HKD","LU1989764664.SGD","LU0080751232.USD","LU2237957902.USD","LU2168564222.USD","LU1803068979.SGD","IE00B775SV38.USD","LU2272731865.HKD","PLOO","LU2023250843.SGD","LU2213496289.HKD","LU1242518857.USD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2617652713","title":"吉利德科学盘中异动 早盘股价大跌3.00%报143.78美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2617652713","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617652713?lang=zh_cn&edition=full","pubTime":"2026-03-06 00:14","pubTimestamp":1772727296,"startTime":"0","endTime":"0","summary":"北京时间2026年03月06日00时14分，吉利德科学股票出现异动，股价急速下跌3.00%。截至发稿，该股报143.78美元/股，成交量120.246万股，换手率0.10%，振幅1.99%。吉利德科学股票所在的制药行业中，整体跌幅为2.25%。吉利德科学公司简介：吉利德科学开发和销售治疗和预防危及生命的传染病的疗法，其投资组合的核心集中在艾滋病毒和乙型肝炎和丙型肝炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306001457a6a76b37&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306001457a6a76b37&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","LU1023059063.AUD","BK4568","BK4139","LU1066051498.USD","LU1430594728.SGD","LU1037948541.HKD","IE00BKVL7J92.USD","LU1839511570.USD","LU0289739699.SGD","LU0965509101.SGD","LU0320765992.SGD","LU0823416689.USD","SG9999015952.SGD","BK4583","LU2468319806.SGD","BK4578","LU2112291526.USD","IE00BSNM7G36.USD","BK4532","LU1674673691.USD","LU1585245621.USD","LU0965509010.AUD","LU1934455863.HKD","BK4550","LU1674673428.USD","SG9999015986.USD","LU1934455194.USD","LU0965508806.USD","LU1057294990.SGD","LU0109394709.USD","IE00BZ1G4Q59.USD","IE0002270589.USD","LU0882574055.USD","IE00B7SZLL34.SGD","LU0861579265.USD","LU1778281490.HKD","SG9999015945.SGD","IE00B3T34201.USD","BK4585","GILD","IE00B19Z3B42.SGD","LU0114720955.EUR","SG9999015978.USD","LU1061106388.HKD","LU2087621335.USD","LU0122379950.USD","LU1037948897.HKD","LU2324357040.USD","LU0234570918.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171545020","title":"吉利德高管称Anito-Cel有望覆盖“高达200亿美元”多发性骨髓瘤市场机遇，考虑一线治疗应用——TD Cowen会议","url":"https://stock-news.laohu8.com/highlight/detail?id=1171545020","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1171545020?lang=zh_cn&edition=full","pubTime":"2026-03-04 00:40","pubTimestamp":1772556015,"startTime":"0","endTime":"0","summary":"在TD Cowen会议上，吉利德科学的高管透露，若将Anito-Cel应用于一线治疗，该疗法有望覆盖多发性骨髓瘤领域“高达200亿美元”的市场机遇。\n这一表态凸显了Anito-Cel在拓展治疗窗口方面的巨大潜力，特别是其在早期治疗阶段可能带来的商业价值。多发性骨髓瘤作为一种恶性血液肿瘤，一线治疗市场的规模庞大，Anito-Cel若能成功切入，将显著提升吉利德在肿瘤治疗领域的竞争力。\n值得注意的是，这一评估基于对现有市场格局和未满足临床需求的深入分析。随着细胞疗法在血液肿瘤领域的不断突破，Anito-Cel的商业前景备受关注。吉利德的战略布局也反映出其对创新疗法长期价值的坚定信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0861579265.USD","LU0882574055.USD","LU2087621335.USD","LU1674673691.USD","LU0823416689.USD","BK4566","LU1061106388.HKD","LU1778281490.HKD","LU0114720955.EUR","LU2089984988.USD","LU1066051498.USD","LU1057294990.SGD","IE00B19Z3B42.SGD","BK4532","IE00B7SZLL34.SGD","LU1066053197.SGD","SG9999015986.USD","SG9999015978.USD","LU0965509283.SGD","SG9999015952.SGD","LU1571399168.USD","LU2324357040.USD","LU0965509101.SGD","BK4583","GILD","IE00B3T34201.USD","LU0965508806.USD","LU1037948541.HKD","BK4550","LU1585245621.USD","IE00BKVL7J92.USD","LU1430594728.SGD","LU1839511570.USD","IE00BSNM7G36.USD","LU0965509010.AUD","LU1037948897.HKD","IE00BZ1G4Q59.USD","IE00B19Z3581.USD","LU1023059063.AUD","BK4585","LU2112291526.USD","LU2468319806.SGD","BK4578","LU0289739699.SGD","LU1674673428.USD","LU0234570918.USD","IE0002270589.USD","BK4588","LU0109394709.USD","BK4139","LU0122379950.USD","LU0889565916.HKD","SG9999015945.SGD","LU0320765992.SGD","BK4568","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120460171","title":"吉利德基金会斥资1200万美元赋能社区卫生工作者，在14个州及哥伦比亚特区扩大艾滋病预防计划","url":"https://stock-news.laohu8.com/highlight/detail?id=1120460171","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1120460171?lang=zh_cn&edition=full","pubTime":"2026-03-02 21:31","pubTimestamp":1772458277,"startTime":"0","endTime":"0","summary":"吉利德基金会近日宣布投入1200万美元资金，旨在强化社区卫生工作者的能力建设，并在全美14个州及哥伦比亚特区大幅拓展艾滋病预防项目。这项重大投资将重点支持基层医疗网络，通过专业培训提升社区健康服务人员的技能水平，同时扩大艾滋病检测、宣传教育及早期干预措施的覆盖范围。\n资金将用于创新预防模式的推广，包括扩大暴露前预防药物的可及性，并针对高危人群开展精准防控。该项目预计将惠及数十万弱势群体，特别是在医疗资源匮乏地区构建更完善的艾滋病防治体系。此次行动展现了基金会通过社区赋能应对公共卫生挑战的战略眼光，有望为全美艾滋病防控网络注入新动能。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0122379950.USD","BK4578","BK4566","IE0002270589.USD","LU1023059063.AUD","LU2468319806.SGD","LU0965509283.SGD","LU1037948541.HKD","BK4585","BK4139","LU0823416689.USD","SG9999015945.SGD","SG9999015986.USD","LU2089984988.USD","LU1061106388.HKD","LU1066051498.USD","LU2087621335.USD","LU0234570918.USD","LU1674673691.USD","LU1839511570.USD","BK4532","IE00B19Z3581.USD","SG9999015952.SGD","LU0114720955.EUR","LU0965509101.SGD","LU1066053197.SGD","LU0861579265.USD","LU1057294990.SGD","SG9999015978.USD","LU0320765992.SGD","LU2324357040.USD","LU0058720904.USD","IE00BZ1G4Q59.USD","LU0289739699.SGD","IE00B7SZLL34.SGD","BK4550","LU0882574055.USD","BK4568","LU0965508806.USD","LU0965509010.AUD","IE00BKVL7J92.USD","LU1037948897.HKD","LU0109394709.USD","IE00BSNM7G36.USD","IE00B19Z3B42.SGD","LU1430594728.SGD","BK4588","LU0889565916.HKD","LU1571399168.USD","LU1674673428.USD","LU1585245621.USD","LU1778281490.HKD","GILD","LU2112291526.USD","BK4583","IE00B3T34201.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613056764","title":"78 亿美元！吉利德收购 Arcellx 加码 CAR-T 赛道","url":"https://stock-news.laohu8.com/highlight/detail?id=2613056764","media":"药时空","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613056764?lang=zh_cn&edition=full","pubTime":"2026-02-24 08:15","pubTimestamp":1771892158,"startTime":"0","endTime":"0","summary":"当地时间 2026 年 2 月 23 日，全球生物制药巨头吉利德科学宣布，将以 78 亿美元隐含股权价值收购临床阶段生物技术公司 Arcellx，此次收购直指后者核心 CAR-T 管线 Anito-cel 与独创的 D-Domain 技术平台，成为吉利德在肿瘤免疫治疗领域的重要布局，也为多发性骨髓瘤治疗赛道注入新动能。交易已获双方董事会批准，预计 2026 年第二季度完成，吉利德目前已持有 Arcellx11.5% 流通股，将通过全资子公司要约收购剩余股份。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022408423997a6bfea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022408423997a6bfea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4583","GILD","LU1839511570.USD","LU2324357040.USD","SG9999015952.SGD","LU0882574055.USD","LU0122379950.USD","IE00B7SZLL34.SGD","LU1066053197.SGD","LU0109394709.USD","LU0965508806.USD","LU0965509283.SGD","LU1037948541.HKD","LU1674673428.USD","LU2468319806.SGD","SG9999015986.USD","BK4230","IE0002270589.USD","LU0114720955.EUR","LU0965509010.AUD","LU1674673691.USD","BK4022","LU0965509101.SGD","LU0889565916.HKD","LU0823416689.USD","LU1037948897.HKD","LU1571399168.USD","IE00BZ1G4Q59.USD","LU1066051498.USD","IE00BSNM7G36.USD","IE00BKVL7J92.USD","BK4588","IE00B3T34201.USD","LU1023059063.AUD","LU2089984988.USD","BK4585","LU1061106388.HKD","LU2112291526.USD","LU0058720904.USD","LU0234570918.USD","IE00B19Z3581.USD","CAR","BK4578","LU1778281490.HKD","LU0289739699.SGD","SG9999015978.USD","BK4566","IE00B19Z3B42.SGD","SG9999015945.SGD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613764020","title":"78亿美金，跨国药企达成闪电并购","url":"https://stock-news.laohu8.com/highlight/detail?id=2613764020","media":"药圈观察局","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613764020?lang=zh_cn&edition=full","pubTime":"2026-02-23 20:03","pubTimestamp":1771848202,"startTime":"0","endTime":"0","summary":"2023年6月，因一名患者死亡，FDA暂停了anito-cel的关键II期临床试验。然而，仅两个月后，FDA经审查解除了搁置，试验重回正轨。同年11月，Kite进一步扩大合作，支付2.85亿美元以获得Arcellx另一条管线ACLX-001的权益，并将对Arcellx的股权投资增至2亿美元，持股比例达到约13%。其市值在不到三年内从不足4亿美元飙升至收购前的数十亿美元，堪称“十倍股”。据悉，此次收购的灵魂是Arcellx的两大核心资产。市场方面，多发性骨髓瘤CAR-T市场预计在2030年达到120亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602232009079541ac53&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602232009079541ac53&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B3T34201.USD","LU0109394709.USD","BK4566","LU1778281490.HKD","LU0234570918.USD","LU0058720904.USD","LU0965509283.SGD","LU1066051498.USD","LU0289739699.SGD","LU0114720955.EUR","LU0965508806.USD","LU1057294990.SGD","BK4585","LU1037948541.HKD","LU0861579265.USD","BK4578","GILD","LU0965509010.AUD","LU1571399168.USD","LU0882574055.USD","LU1674673691.USD","BK4550","SG9999015945.SGD","SG9999015986.USD","IE00BZ1G4Q59.USD","LU0320765992.SGD","IE00B7SZLL34.SGD","LU2324357040.USD","SG9999015952.SGD","LU1066053197.SGD","IE00BKVL7J92.USD","LU2468319806.SGD","LU1061106388.HKD","BK4568","LU1674673428.USD","LU1037948897.HKD","LU2089984988.USD","LU0122379950.USD","BK4583","BK4139","IE00B19Z3581.USD","IE00B19Z3B42.SGD","LU0823416689.USD","BK4588","IE0002270589.USD","LU2087621335.USD","LU0889565916.HKD","IE00BSNM7G36.USD","ORR","CVR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177273649","title":"特定条件下交易终止  Arcellx将向吉利德科学支付2.6亿美元解约金","url":"https://stock-news.laohu8.com/highlight/detail?id=1177273649","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1177273649?lang=zh_cn&edition=full","pubTime":"2026-02-23 19:51","pubTimestamp":1771847474,"startTime":"0","endTime":"0","summary":"根据协议条款约定，若本次合作因特定情形提前终止，生物技术公司Arcellx须向吉利德科学支付高达2.6亿美元的终止费用。该条款作为交易保护机制，旨在保障吉利德科学的权益，同时反映出双方对合作价值的共同认可。\n交易文件明确规定，解约金的触发条件与终止情形直接关联，具体条款细节未完全公开。这一安排既体现了交易双方对合作稳定性的重视，也为可能出现的意外情况提供了明确的解决方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823416689.USD","SG9999015945.SGD","LU2087621335.USD","LU1037948541.HKD","LU1061106388.HKD","LU0882574055.USD","LU1674673691.USD","IE00BZ1G4Q59.USD","LU1585245621.USD","LU0965509101.SGD","LU0861579265.USD","LU0122379950.USD","LU2468319806.SGD","BK4550","LU1037948897.HKD","LU1571399168.USD","BK4139","IE00BKVL7J92.USD","GILD","LU0058720904.USD","LU1778281490.HKD","LU0965509283.SGD","SG9999015952.SGD","LU1839511570.USD","IE00B3T34201.USD","IE00B19Z3581.USD","BK4585","LU1430594728.SGD","SG9999015978.USD","BK4578","LU0234570918.USD","LU1057294990.SGD","BK4566","SG9999015986.USD","IE00BSNM7G36.USD","LU2112291526.USD","LU0289739699.SGD","BK4583","LU0965509010.AUD","LU0965508806.USD","BK4532","LU1066053197.SGD","LU1674673428.USD","LU2089984988.USD","IE00B7SZLL34.SGD","BK4568","LU1066051498.USD","BK4588","LU1023059063.AUD","LU2324357040.USD","LU0109394709.USD","LU0114720955.EUR","IE00B19Z3B42.SGD","LU0320765992.SGD","LU0889565916.HKD","IE0002270589.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613786707","title":"吉利德科学公司盘前股价下跌1.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613786707","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613786707?lang=zh_cn&edition=full","pubTime":"2026-02-23 19:18","pubTimestamp":1771845484,"startTime":"0","endTime":"0","summary":"吉利德科学公司盘前股价下跌1.3%","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202602233651998235.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202602233651998235.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU2112291526.USD","BK4532","BK4588","LU1061106388.HKD","LU0889565916.HKD","LU0289739699.SGD","BK4550","LU0058720904.USD","IE00B3T34201.USD","SG9999015978.USD","LU1037948897.HKD","LU0965509010.AUD","LU0882574055.USD","BK4585","LU0320765992.SGD","BK4566","LU0114720955.EUR","LU1674673428.USD","LU1057294990.SGD","LU2468319806.SGD","LU0965508806.USD","LU0965509283.SGD","BK4568","LU0965509101.SGD","LU0861579265.USD","LU1066053197.SGD","LU1585245621.USD","LU0234570918.USD","LU1674673691.USD","LU2324357040.USD","LU1839511570.USD","IE00B7SZLL34.SGD","LU0823416689.USD","IE00BKVL7J92.USD","LU0122379950.USD","IE00BSNM7G36.USD","GILD","LU2087621335.USD","LU1571399168.USD","LU1430594728.SGD","LU0109394709.USD","LU2089984988.USD","LU1778281490.HKD","SG9999015945.SGD","BK4578","IE00B19Z3B42.SGD","SG9999015952.SGD","LU1023059063.AUD","IE0002270589.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118834824","title":"盘前异动  | Arcellx涨超75%，吉利德科学拟以每股115美元收购","url":"https://stock-news.laohu8.com/highlight/detail?id=1118834824","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1118834824?lang=zh_cn&edition=full","pubTime":"2026-02-23 19:05","pubTimestamp":1771844747,"startTime":"0","endTime":"0","summary":"2月23日，Arcellx盘前涨超75%，吉利德科学将以每股115美元的价格收购Arcellx。","market":"us","thumbnail":"https://static.tigerbbs.com/017a2d51f9605f643f552ed0e3997176","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/017a2d51f9605f643f552ed0e3997176"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"1ad4b20488406cf4948c2f1a2f067a59","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","LU1037948541.HKD","LU1674673691.USD","LU0320765992.SGD","LU0882574055.USD","BK4568","IE00B7SZLL34.SGD","LU0823416689.USD","BK4578","LU1674673428.USD","LU0861579265.USD","LU1066053197.SGD","LU1037948897.HKD","BK4585","LU0122379950.USD","LU1585245621.USD","LU1839511570.USD","LU2087621335.USD","LU0965508806.USD","BK4588","IE00B19Z3581.USD","BK4139","GILD","LU0109394709.USD","BK4566","LU0058720904.USD","LU0289739699.SGD","LU2089984988.USD","SG9999015978.USD","LU1571399168.USD","IE00BKVL7J92.USD","LU2468319806.SGD","LU1057294990.SGD","IE00B19Z3B42.SGD","SG9999015945.SGD","LU0114720955.EUR","BK4583","LU0889565916.HKD","LU1061106388.HKD","LU0965509101.SGD","LU2324357040.USD","SG9999015986.USD","LU0965509283.SGD","LU1066051498.USD","ACLX","LU0234570918.USD","LU2112291526.USD","IE00BZ1G4Q59.USD","LU1430594728.SGD","IE00B3T34201.USD","SG9999015952.SGD","IE00BSNM7G36.USD","LU1023059063.AUD","LU1778281490.HKD","IE0002270589.USD","BK4550","LU0965509010.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2611199965","title":"巴克莱四季度增持美光科技等五股，减持英伟达微软等","url":"https://stock-news.laohu8.com/highlight/detail?id=2611199965","media":"DoNews","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611199965?lang=zh_cn&edition=full","pubTime":"2026-02-14 07:12","pubTimestamp":1771024321,"startTime":"0","endTime":"0","summary":"2026年2月14日，巴克莱银行披露2025年四季度13F持仓文件。该公司当季增持美光科技、谷歌C类股、吉利德科学、应用材料及Kenvue；减持英伟达、微软、摩根大通、百事和苹果。截至期末，其前五大重仓股为英伟达（占比5.3%）、微软、苹果、亚马逊和谷歌A类股。调整主因系对半导体周期、AI算力需求及医药板块估值的再平衡。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260214071342a4a24aa8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260214071342a4a24aa8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0354030511.USD","LU0985320562.USD","LU0823434740.USD","IE00BJTD4V19.USD","LU0557290698.USD","IE00BJTD4N35.SGD","2NVD.UK","LU2298321311.HKD","NVDY","BK4587","LU0757359954.USD","BK4512","LU0444971666.USD","LU2860962120.EUR","LU2092937221.SGD","LU2347655073.USD","LU0096364046.USD","SGXZ99366536.SGD","LU0820561909.HKD","LU1803068623.USD","LU2272731782.SGD","LU0057025933.USD","LU2360106780.USD","LU2360032135.SGD","LU2487616109.SGD","IE00BN8TJ469.HKD","LU2417539215.USD","04336","LU2362541513.USD","LU1674673428.USD","LU1582987324.SGD","HK0000306701.USD","LU1623119135.USD","SG9999014567.USD","LU1323610961.USD","LU0889565833.HKD","LU1066053197.SGD","LU1069347547.HKD","LU1496350171.SGD","LU1791710582.SGD","KVUE","LU2602419157.SGD","JPM","LU0642271901.SGD","LU2756315318.SGD","SG9999018865.SGD","LU0053666078.USD","LU2750360997.AUD","IE0034235295.USD","LU0314106906.USD","LU0158827781.USD","LU2168564065.EUR","LU1670710661.SGD","IE00BSNM7G36.USD","BK4579","LU2264538146.SGD","LU1228905037.USD","LU2452424414.USD","LU1037948897.HKD","LU2063271972.USD","LU0965509283.SGD","LU1951198990.SGD","LU1267930490.SGD","LU2111349929.HKD","IE00BKVL7J92.USD","LU2092627202.USD","LU2237443978.SGD","LU0476273544.USD","IE00BQXX3F31.USD","LU2471134523.USD","LU2242649171.HKD","LU1121112475.USD","LU2290526834.HKD","LU0345770993.USD","LU0345774631.USD","HK0000306685.HKD","LU2125909247.SGD","SG9999001424.SGD","GB00BDT5M118.USD","BK4576","LU2361044865.SGD","MSFX","LU2077746001.SGD","LU1629891620.HKD","LU1721428933.USD","LU2191332357.HKD","LU2065170008.USD","LU0048584097.USD","LU0823414478.USD","LU2048586759.USD","LU1989764748.USD","IE0034235188.USD","BK4551","BK4527","BK4598","LU2087625088.SGD","LU0124676726.USD","LU1435385759.SGD","LU1244550221.USD","LU0820562030.AUD","IE00B19Z3B42.SGD","LU2491050071.SGD","LU2592432038.USD","BK4529","LU2506952097.USD","LU1261432733.SGD","SG9999015986.USD","LU1868836757.USD","SG9999001077.SGD","LU0234570918.USD","LU1035773651.USD","LU0672654240.SGD","LU2168564149.EUR","NVDW","SG9999014880.SGD","BK4554","LU0960925559.SGD","LU1221951046.USD","LU1691799644.USD","LU0158827948.USD","IE00BK4W5M84.HKD","LU1066051811.HKD","IE00B3S45H60.SGD","LU1267930813.SGD","LU0943347566.SGD","IE00BK4W5L77.USD","LU2125154935.USD","LU1670711123.USD","IE00B7SZLL34.SGD","LU0077335932.USD","LU0965509010.AUD","LU1989772840.SGD","LU0234572021.USD","LU2326559502.SGD","IE00BLSP4452.SGD","LU2237443382.USD","LU0795875169.SGD","LU2506952170.USD","LU1059921491.USD","LU2210149790.SGD","LU1935042991.SGD","LU1232071149.USD","LU0640476718.USD","LU1868837300.USD","LU2360107168.USD","SG9999015341.SGD","LU1430594728.SGD","IE00B19Z9505.USD","LU1992135472.HKD","LU2746668974.SGD","LU2041044095.USD","LU0316494557.USD","MSFY","LU0069063385.USD","LU2420271590.USD","LU0289961442.SGD","LU1983260115.SGD","LU1366333091.USD","LU2764263039.SGD","LU0949170426.SGD","LU2065171311.SGD","LU0210533765.USD","LU2237443465.HKD","LU1935042488.USD","LU1582986433.USD","LU1242518931.SGD","IE0009G5SDU7.USD","LU1923622614.USD","LU1548497426.USD","LU2322448957.HKD","LU0312595415.SGD","LU1923623000.USD","LU2381873111.SGD","IE00BN29S564.USD","LU1221951129.SGD","NVDA","LU2148611432.USD","LU0545039389.USD","IE00BDRTCR15.USD","LU1145028129.USD","LU1670711040.USD","LU1815336760.USD","IE00BBT3K403.USD","LU0011850046.USD","LU2271345857.HKD","LU0345768740.USD","LU0308772762.SGD","LU2430703251.USD","LU0203345920.USD","LU1718418525.SGD","IE0004086264.USD","LU2083900584.USD","LU0251132253.USD","LU2092937148.SGD","LU2746668461.USD","LU1564329461.SGD","LU0426417589.USD","LU2087621335.USD","LU0868494708.USD","LU0871640123.AUD","LU1778281490.HKD","LU0823434583.USD","LU0072461881.USD","LU2065171402.SGD","LU1242518857.USD","LU2404859741.USD","LU1823568750.SGD","LU1069344957.HKD","LU2764262908.HKD","HK0000914686.HKD","LU1196500208.SGD","IE00B19Z8W00.USD","SG9999015945.SGD","LU0323240290.USD","BK4543","LU1236620834.HKD","LU1868837136.USD","LU1043141123.HKD","BK4553","LU0417517546.SGD","LU2720916845.USD","IE00BDCRKT87.USD","LU0345768153.USD","LU1506573853.SGD","LU1923622291.USD","LU2357125470.USD","LU2294711713.HKD","LU2237438978.USD","LU1066051498.USD","IE0001KFT4U8.USD","LU2471134879.HKD","LU0823421416.USD","SGXZ51526630.SGD","BK4535","LU1235294995.USD","IE000ITXATA3.USD","LU0795875086.SGD","LU1551013342.USD","LU0154236417.USD","IE00BKPKM429.USD","IE00BZ199S13.USD","IE00B19Z3581.USD","LU0082616367.USD","LU0511384066.AUD","LU2764263203.CNY","LU0994945656.USD","LU0310799852.SGD","IE00B4JS1V06.HKD","BK4577","SG9999014898.SGD","LU1732800096.USD","LU1235295455.SGD","LU0256863902.USD","LU1116320737.USD","LU1244550494.USD","LU0390134368.USD","IE000KEQY171.SGD","LU2473716301.USD","LU1564329032.USD","LU1316542783.SGD","LU0545562505.USD","SG9999015952.SGD","LU0868494617.USD","IE0002270589.USD","BK4612","LU0353189680.USD","MSFW","LU2456880835.USD","GB00B4QBRK32.GBP","LU2247934214.USD","MUD","IE0004445239.USD","LU0274383776.USD","LU2506951875.HKD","IE00BMPRXN33.USD","GILD","LU0106261372.USD","LU2097344431.USD","BK4532","LU1267930573.SGD","LU0708994859.HKD","LU2089284900.SGD","MSFD","PEP","LU1642822529.SGD","LU2125909916.SGD","LU1989773731.SGD","LU0187121727.USD","LU0345769128.USD","LU0823417653.USD","BK4614","LU1551013425.SGD","LU0310800379.SGD","LU0894485498.HKD","LU1280957306.USD","BK4528","LU0820561818.USD","IE00BQXX3C00.GBP","LU2054465674.USD","LU1951200564.SGD","LU0784383803.USD","LU2237443895.HKD","LU0861579265.USD","LU2237957811.SGD","LU1366192091.USD","LU0070217475.USD","BK4605","LU1697837992.HKD","LU0957791311.USD","LU1116320901.HKD","LU2236285917.USD","SG9999014906.USD","LU2023250504.SGD","BK4525","LU2168563687.JPY","LU1633808545.USD","LU1127390331.HKD","IE00B7KXQ091.USD","IE00BFSS8Q28.SGD","LU0198837287.USD","LU2506951792.HKD","LU0528227936.USD","IE00B775H168.HKD","SG9999014575.USD","LU1934455277.USD","LU2361045086.USD","3NVD.UK","LU0267386448.USD","NVD2.UK","LU2023250330.USD","LU0345770308.USD","SGXZ23171101.USD","BK4575","LU2360108059.USD","IE00BMPRXQ63.HKD","LU0061475181.USD","LU1935043023.USD","LU1496350502.SGD","LU1188199696.SGD","LU1974910355.USD","LU2237443622.USD","LU1839511570.USD","IE00BHPRN162.USD","LU0096362180.USD","SG9999004303.SGD","LU0965508806.USD","IE00B5949003.HKD","MSFT","SG9999015978.USD","BK4608","SG9999018857.SGD","LU2097829019.USD","BK4585","LU2505996681.GBP","LU0444973449.USD","LU2413666426.HKD","IE00BJLML261.HKD","LU0203201768.USD","LU2471134796.USD","IE00B3SWFQ91.USD","LU1571399168.USD","LU0157215616.USD","LU0149725797.USD","LU2242650005.HKD","LU1064131342.USD","LU2286300806.USD","HK0000320264.USD","NVDQ","LU0787776722.HKD","LU0689472784.USD","IE00B5TLWC47.USD","IE000YTNTUN2.SGD","LU0345769631.USD","LU1119994496.HKD","NVDU","IE00BLSP4239.USD","LU0690374615.EUR","LU0708995401.HKD","SG9999002232.USD","LU1032466523.USD","IE0004091025.USD","IE00B3M56506.USD","LU2552382215.SGD","LU2430703178.SGD","BK4538","LU1699723380.USD","LU1670628061.USD","LU0784384876.USD","BK4503","IE0004445015.USD","LU2097344357.USD","BK4533","GB00B4LPDJ14.GBP","LU2125909593.SGD","LU0894486033.HKD","LU0095938881.EUR","LU2750360641.GBP","BK4097","LU2108987350.USD","MSFU","LU0466842654.USD","LU1340139317.AUD","SNVD.UK","DIPS","MSFO","LU0097036916.USD","LU0342679015.USD","LU0788109477.HKD","LU2244417387.USD","LU1035775433.USD","MU","BK4534","BK4504","LU0690374961.EUR","LU0823417737.USD","LU2168564495.EUR","LU1066051225.USD","IE00BYXW3230.USD","LU2361044949.HKD","SG9999015358.SGD","LU0203347892.USD","IE0003U64NQ7.SGD","BK4141","LU2505996509.AUD","IE0034235303.USD","LU2023251221.USD","NVDS","BK4548","LU0323591593.USD","LU1181866309.USD","LU0784385170.HKD","LU1861215975.USD","LU2896262040.SGD","LU0661504455.SGD","LU0689626769.HKD","LU2462157665.USD","IE00BKDWB100.SGD","LU1582987597.SGD","LU0265550946.USD","LU0784385840.USD","NVIW.SI","LU2133065610.SGD","LU1003077747.HKD","IE00BFSS7M15.SGD","LU0266013472.USD","LU0238689110.USD","LU2458330243.SGD","LU1804176565.USD","LU2125909759.SGD","LU1868836591.USD","LU0215105999.USD","IE00B1XK9C88.USD","LU0456855351.SGD","LU2506951958.HKD","NVDD","LU0347712357.USD","LU0302445910.USD","LU2089985449.USD","LU1236620750.USD","LU0957808578.USD","LU0942090050.USD","LU2362540622.SGD","LU0726765562.USD","LU0683600562.USD","IE00BJJMRX11.SGD","LU0348723411.USD","LU1429558221.USD","LU0006306889.USD","LU1720051108.HKD","LU1917777945.USD","LU2756315664.SGD","LU1046421795.USD","MSFL","LU1334329650.SGD","LU0738911758.USD","LU0211327993.USD","LU1670710588.SGD","LU1228905540.USD","LU2413666699.HKD","LU0494093205.USD","LU1914381329.SGD","LU0757359368.USD","LU0823421333.USD","LU0079474960.USD","IE00BWXC8680.SGD","LU2491049909.HKD","LU0029864427.USD","LU0081259029.USD","HK0000914660.USD","LU1815333072.USD","LU0256863811.USD","LU1153585028.USD","LU1934455863.HKD","LU1989772923.USD","LU0210528500.USD","LU1814569148.SGD","LU1935043536.SGD","LU0889566641.SGD","LU0964807845.USD","LU2125154778.USD","LU0225283273.USD","LU0879622024.SGD","IE00BJJMRY28.SGD","LU0354030438.USD","LU0719512351.SGD","SG9999002224.SGD","SG9999014559.SGD","BK4566","SGXZ31699556.SGD","LU1037948541.HKD","NVDG","LU0289739343.SGD","LU0320765059.SGD","LU2237443549.SGD","LU0553294199.USD","LU1244550577.SGD","LU0203202063.USD","LU0289941410.SGD","LU1564329628.SGD","LU0792757196.USD","LU1861220033.SGD","LU0107464264.USD","LU2265009873.SGD","LU1301847155.USD","LU2362541273.HKD","LU2403377893.USD","LU0426412945.USD","LU2357305700.SGD","IE00BZ1G4Q59.USD","LU2931357623.SGD","LU0353189763.USD","LU1564329115.USD","LU0127658192.USD","LU2279689827.SGD","LU0786609619.USD","LU0314104364.USD","LU1732799900.SGD","IE00BD6J9T35.USD","LU2211815571.USD","LU2347655156.SGD","LU2471134952.CNY","LU1084165304.USD","LU1670627923.USD","LU0109391861.USD","LU0965509101.SGD","LU2210150020.SGD","LU0094547139.USD","LU1267930730.SGD","LU0171293334.USD","LU0109392836.USD","IE0005OL40V9.USD","SG9999014914.USD","LU0472753341.HKD","IE00B1BXHZ80.USD","NVII","SGXZ81514606.USD","LU0345774391.USD","LU0882574139.USD","LU1074936037.SGD","NVDS.UK","LU0912757837.SGD","LU0950375773.USD","LU1852331112.SGD","LU0061474705.USD","LU1043141396.HKD","LU1868836914.USD","MULL","IE00B4YYXB79.USD","LU0128525929.USD","LU2463028550.USD","LU1582986359.USD","LU2322448791.USD","LU0823414551.USD","LU1935042215.USD","LU0949170772.SGD","LU0175139822.USD","LU2430703095.HKD","LU2543165471.USD","LU1934455194.USD","LU0289960550.SGD","LU1712237335.SGD","LU2491050154.USD","BK4588","IE00B19Z8X17.USD","LU1988902786.USD","LU0323239441.USD","LU1674673691.USD","LU2404859667.USD","LU2552382058.USD","IE00BQXX3D17.EUR","LU2095319765.USD","SG9999000418.SGD","LU0061474960.USD","BK4592","LU1989763005.USD","NVD3.UK","LU0072462426.USD","LU1032955483.USD","LU2272731600.USD","LU2433249047.HKD","BK4516","LU1861127337.USD","LU1992135399.USD","LU0056508442.USD","BK4581","BK4549","BK4567","LU2461242641.AUD","LU2089283258.USD","LU2552382132.HKD","LU0210536198.USD","LU1821325948.USD","LU1720051017.SGD","NVD","LU2106854487.HKD","SG9999017495.SGD","LU2065169927.USD","LU2458330169.SGD","SG9999014542.SGD","IE00BMPRXR70.SGD","LU2028103732.USD","LU0979878070.USD","IE000W1ABFV2.USD","IE0009356076.USD","LU2275660780.HKD","LU1585245621.USD","LU0170899867.USD","HK0000320223.HKD","LU0211328371.USD","LU1989764664.SGD","LU2249611893.SGD","LU2250418816.HKD","LU0080751232.USD","LU2237957902.USD","LU2168564222.USD","LU1791710400.SGD","LU0162691827.USD","LU1803068979.SGD","IE00B775SV38.USD","IE00BYQQ9H92.USD","LU0265550359.USD","BK4550","IE00BFXG0V08.USD","LU2272731865.HKD","LU0276348264.USD","LU2023250843.SGD","LU2213496289.HKD","LU0724617625.USD","NVDX"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.gilead.com","stockEarnings":[{"period":"1week","weight":0.0207},{"period":"1month","weight":-0.0549},{"period":"3month","weight":0.1489},{"period":"6month","weight":0.2398},{"period":"1year","weight":0.2486},{"period":"ytd","weight":0.1383}],"compareEarnings":[{"period":"1week","weight":0.0166},{"period":"1month","weight":-0.036},{"period":"3month","weight":-0.04},{"period":"6month","weight":-0.02},{"period":"1year","weight":0.1617},{"period":"ytd","weight":-0.0383}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"吉利德科学公司于1987年6月22日在特拉华州成立，是一家以研究为基础的生物制药公司，致力于发现，开发和商业化未满足医疗需求的创新药物。该公司的主要重点领域包括病毒性疾病，炎性和纤维化疾病以及肿瘤学。","yearOnYearQuotes":[{"month":1,"riseRate":0.588235,"avgChangeRate":0.044916},{"month":2,"riseRate":0.428571,"avgChangeRate":0.008369},{"month":3,"riseRate":0.514286,"avgChangeRate":-0.011268},{"month":4,"riseRate":0.542857,"avgChangeRate":0.011701},{"month":5,"riseRate":0.558824,"avgChangeRate":0.0204},{"month":6,"riseRate":0.647059,"avgChangeRate":0.025673},{"month":7,"riseRate":0.558824,"avgChangeRate":0.01609},{"month":8,"riseRate":0.558824,"avgChangeRate":0.033158},{"month":9,"riseRate":0.558824,"avgChangeRate":0.031157},{"month":10,"riseRate":0.529412,"avgChangeRate":0.003173},{"month":11,"riseRate":0.647059,"avgChangeRate":0.039736},{"month":12,"riseRate":0.382353,"avgChangeRate":0.010114}],"exchange":"NASDAQ","name":"吉利德科学","nameEN":"Gilead Sciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.39.0","shortVersion":"4.39.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"吉利德科学(GILD)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供吉利德科学(GILD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"吉利德科学,GILD,吉利德科学股票,吉利德科学股票老虎,吉利德科学股票老虎国际,吉利德科学行情,吉利德科学股票行情,吉利德科学股价,吉利德科学股市,吉利德科学股票价格,吉利德科学股票交易,吉利德科学股票购买,吉利德科学股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"吉利德科学(GILD)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供吉利德科学(GILD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}